<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neurol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurol. Sci</journal-id>
<journal-title-group>
<journal-title>Neurological Sciences</journal-title>
</journal-title-group>
<issn pub-type="ppub">1590-1874</issn>
<issn pub-type="epub">1590-3478</issn>
<publisher>
<publisher-name>Springer Milan</publisher-name>
<publisher-loc>Milan</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28078565</article-id>
<article-id pub-id-type="pmc">5331099</article-id>
<article-id pub-id-type="publisher-id">2802</article-id>
<article-id pub-id-type="doi">10.1007/s10072-016-2802-8</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The influence of sodium on pathophysiology of multiple sclerosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zostawa</surname>
<given-names>Jacek</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Adamczyk</surname>
<given-names>Jowita</given-names>
</name>
<address>
<phone>+48 32 3704584</phone>
<email>jowitkaa@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sowa</surname>
<given-names>Paweł</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Adamczyk-Sowa</surname>
<given-names>Monika</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2198 0923</institution-id><institution-id institution-id-type="GRID">grid.411728.9</institution-id><institution>Department of Neurology in Zabrze, </institution><institution>Medical University of Silesia, </institution></institution-wrap>ul. 3-go Maja 13-15, 41-800 Zabrze, Poland </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2198 0923</institution-id><institution-id institution-id-type="GRID">grid.411728.9</institution-id><institution>Department of Otorhinolaryngology and Oncological Laryngology, </institution><institution>Medical University of Silesia, </institution></institution-wrap> ul. C. Skłodowskiej 10, 41-800 Zabrze, Poland </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>11</day>
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>11</day>
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2017</year>
</pub-date>
<volume>38</volume>
<issue>3</issue>
<fpage>389</fpage>
<lpage>398</lpage>
<history>
<date date-type="received">
<day>7</day>
<month>8</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>12</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2017</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p>Multiple sclerosis (MS) is a chronic, inflammatory, autoimmune disease of the central nervous system, and is an important cause of disability in young adults. In genetically susceptible individuals, several environmental factors may play a partial role in the pathogenesis of MS. Some studies suggests that high-salt diet (&gt;5 g/day) may contribute to the MS and other autoimmune disease development through the induction of pathogenic Th17 cells and pro-inflammatory cytokines in both humans and mice. However, the precise mechanisms of pro-inflammatory effect of sodium chloride intake are not yet explained. The purpose of this review was to discuss the present state of knowledge on the potential role of environmental and dietary factors, particularly sodium chloride on the development and course of MS.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Sodium chloride intake</kwd>
<kwd>Multiple sclerosis</kwd>
<kwd>Environmental factors in MS</kwd>
<kwd>VGSCs</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Springer-Verlag Italia 2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p>Multiple sclerosis (MS) is a chronic, inflammatory, autoimmune disease of the central nervous system (CNS), and is a major cause of disability in young adults [<xref ref-type="bibr" rid="CR1">1</xref>]. In genetically susceptible individuals, environmental factors play a significant partial role in the pathogenesis of MS [<xref ref-type="bibr" rid="CR2">2</xref>]. Numerous studies examined the influence of environmental factors, such as Epstein–Barr infection [<xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR5">5</xref>], vitamin D levels [<xref ref-type="bibr" rid="CR6">6</xref>–<xref ref-type="bibr" rid="CR11">11</xref>], smoking [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>], obesity [<xref ref-type="bibr" rid="CR14">14</xref>], sunlight exposure [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], and geographic variation, on MS [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>].</p>
</sec>
<sec id="Sec2">
<title>Methodology</title>
<p>All quotable references were searched using Pubmed and Google scholar between March and May 2016. References that allowed free access to full text by the Medical University of Silesia were retrieved and read. The oldest publications were retrieved from the Medical University of Silesia Library. One reviewer performed literature searches and two other researchers independently screened the articles. All disagreements were discussed and resolved by the authors or in consultation with other experts. Information used in our review was evaluated using evidence-based medicine. Inclusion criteria for the articles were: original papers, systematic reviews, systematic summaries, and meta-analysis. We excluded publications written in foreign languages, such as Spanish, German, or Russian. Keywords used for literature searches were as follows: “multiple sclerosis”, “MS”, “sodium”, “sodium chloride”, “autoimmunity”, “diet”, and “VGSCs”. All keywords were in accordance with the MeSH terms. To identify the appropriate publications, we searched Pubmed and Google scholar using combinations of keywords in the following order: “MS and diet”, “MS and salt intake”, “MS and environmental factors,” and “MS and VGSCs”. After reading titles and abstracts, some articles from each combination of keywords were excluded. Most of the excluded articles were in a foreign language. The comprehensive literature search identified 907 articles that were relevant for our review. Titles, abstracts, or full articles were reviewed to determine whether each search result matched our selection criteria. We also reviewed the references of the selected original papers and review articles found by our search for additional papers relevant to our review. Only high-quality publications from the last decades were included. In addition, 306 articles were retrieved from the Medical University of Silesia Library. Of these 306 articles, we eliminated those that were too general in scope for our review.</p>
</sec>
<sec id="Sec3">
<title>Environmental factors influencing MS</title>
<p>Although some studies confirmed the link between a previous infection with Epstein–Barr virus (EBV) and the development of multiple sclerosis [<xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR19">19</xref>–<xref ref-type="bibr" rid="CR21">21</xref>], the involvement of EBV in the etiology of MS is unclear. However, certain viral infections likely increase susceptibility to MS [<xref ref-type="bibr" rid="CR22">22</xref>]. Sero-epidemiological studies have demonstrated that almost 100% of adult MS patients are infected with EBV [<xref ref-type="bibr" rid="CR19">19</xref>]. Late childhood infection of EBV is proposed to be the serious risk factor for the disease. Moreover, there is a strong EBV-specific CD8+ response in the blood of MS patients in the beginning of the disease and the intensity decreases in the course of the illness [<xref ref-type="bibr" rid="CR2">2</xref>–<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>].</p>
<p>Low serum vitamin D levels are currently one of the most studied environmental factors influencing the development of MS. It has been shown that intake of food rich in vitamin D significantly prevents the development of MS or reduce activity of the disease [<xref ref-type="bibr" rid="CR6">6</xref>–<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Nevertheless, some authors did not report a protective role of vitamin D supplementation for the development of MS [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>].</p>
<p>Smoking is another possible factor for the development of MS or might be responsible for worst prognosis of course of the disease [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Furthermore, smoking cessation improved the prognosis in patients with MS. Ramanujam et al. confirmed that the time to conversion to secondary progressive MS (SPMS) decreases by 4.7% for each additional year of smoking after the diagnosis in patients with RRMS (acceleration factor 1.047; 95% CI 1.023–1.072; <italic>P</italic>  &lt;  0.01) [<xref ref-type="bibr" rid="CR13">13</xref>].</p>
<p>Obesity is a probable susceptibility factor for MS and several other autoimmune diseases [<xref ref-type="bibr" rid="CR24">24</xref>], but the relationship between increased body mass index (BMI) and disease activity has not been fully explained. There is no doubt that obesity increases levels of pro-inflammatory cytokines and is associated with low-grade inflammatory state [<xref ref-type="bibr" rid="CR25">25</xref>]. There are reports providing that RRMS activity is higher in obese and overweight patients than in patients with normal BMI undergoing IFN β treatment [<xref ref-type="bibr" rid="CR14">14</xref>]. Moreover, Oliveira et al. reported a positive relationship between elevated BMI and disability in MS patients [<xref ref-type="bibr" rid="CR26">26</xref>].</p>
<p>Ultraviolet radiation was proposed to be a significant environmental factor influencing prevalence of the disease [<xref ref-type="bibr" rid="CR15">15</xref>]. Reduced risk of MS through exposure to sunlight is probably mediated not only by increased production of vitamin D in the skin, but also by the synthesis of anti-inflammatory factors, such as IL-10, TNF-α, and Treg cells [<xref ref-type="bibr" rid="CR16">16</xref>]. Therefore, the latitude is nowadays considered to be related with prevalence of MS. The disease is less frequent near the equator and more frequent in northern countries [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Exceptions to this trend, namely, Sardinia, where the prevalence of the disease is significantly higher [<xref ref-type="bibr" rid="CR28">28</xref>], and northern Scandinavia, with markedly low prevalence [<xref ref-type="bibr" rid="CR29">29</xref>], may be due to genetic and behavioral factors [<xref ref-type="bibr" rid="CR18">18</xref>].</p>
</sec>
<sec id="Sec4">
<title>Influence of diet on MS</title>
<p>It seems that diet might have a significant relationship with the inflammatory process of MS. Many studies have shown that diet plays the role in the pathogenesis of MS [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR30">30</xref>–<xref ref-type="bibr" rid="CR32">32</xref>]. Recent studies have provided the evidence for a protective role of polyunsaturated fatty acids on the risk of MS; however, there is no conclusive evidence for a beneficial role of polyunsaturated fatty acid supplementation in patients with MS. Hoare et al. demonstrated that the amount of omega-3 polyunsaturated fatty acids taken orally is inversely proportional to the risk of demyelination in the CNS [<xref ref-type="bibr" rid="CR33">33</xref>]. Moreover, Khalili et al. found a strong correlation between oral intake of lipoic acid (1.2 mg/day) and decrease in the levels of pro-inflammatory cytokines, including INF-γ, ICAM-1, and anti-inflammatory cytokines, including TGF-β and IL-4, compared with placebo group [<xref ref-type="bibr" rid="CR35">35</xref>]. On the other hand, Torkildsen et al. showed that consumption of omega-3 fatty acids used as monotherapy or in combination with interferon beta-1a had no beneficial effect on the disease compared to placebo [<xref ref-type="bibr" rid="CR34">34</xref>]. Retinoic acid (RA), an active metabolite of vitamin A, revealed a strong immunosuppressive activity [<xref ref-type="bibr" rid="CR36">36</xref>]. RA has been shown to modulate the balance between Th1/Th2 and Th17/Treg cells and B cell function, contributing to augmented tolerance and inhibited inflammatory response. It also contributes to enhanced tolerance and reduction of inflammatory effects [<xref ref-type="bibr" rid="CR37">37</xref>]. Bitarafan et al. investigated the impact of vitamin A on disease progression in MS patients. The study evaluated the expanded disability status scale (EDSS) and MS functional composite (MSFC). The results showed that vitamin A improved MSFC in RRMS patients, but did not affect EDSS, relapse rate, or active brain lesions in MRI [<xref ref-type="bibr" rid="CR38">38</xref>]. Ketogenic diet (high amount of fat, decreased protein content, and very low carbohydrates) was shown as potentially therapeutic in progressive forms of MS, which is especially relevant, because currently, there is no treatment for progressive forms of the disease [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. Kim et al. reported that ketogenic diet improved motor disability and cognitive impairment in mice with experimental autoimmune encephalomyelitis compared with mice on the standard diet. Furthermore, a ketogenic diet reversed structural brain lesions and reduced CNS inflammation and oxidative stress [<xref ref-type="bibr" rid="CR41">41</xref>]. On the other hand, it was reported that creatine supplementation did not improve muscle capacity or habitual fatigue in MS individuals [<xref ref-type="bibr" rid="CR42">42</xref>] or that restricted intake of animal fat (no more than 10–15 g/day) caused remission of the disease in patients with RRMS [<xref ref-type="bibr" rid="CR43">43</xref>].</p>
<p>Polyphenols and carotenoids from vegetables, n-3 PUFA from fish, vitamins A, C, D, and E, thiol compounds, such as lipoic acid, and oligoelements, such as selenium and magnesium, have anti-oxidant properties [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. Th17 cells, which produce pro-inflammatory cytokines, are increased, whereas Treg cells are decreased in MS, and thus, the balance between Th17 and Treg cells is impaired in this disease. Vitamin A and its active metabolites (all-trans-retinoic acid and 9-<italic>cis</italic>-retinoic acid) modulate the imbalance of Th17 and Treg cells and might be beneficial to the prevention and treatment of MS [<xref ref-type="bibr" rid="CR46">46</xref>]. Moreover, this vitamin was proposed to have a beneficial effect during interferon therapy and improved psychiatric outcomes for anti-inflammatory mechanisms [<xref ref-type="bibr" rid="CR37">37</xref>].</p>
</sec>
<sec id="Sec5">
<title>Sodium channels in MS</title>
<p>Voltage-gated sodium channels (VGSCs) are key mediators of action potential initiation and propagation in excitable cells [<xref ref-type="bibr" rid="CR47">47</xref>–<xref ref-type="bibr" rid="CR49">49</xref>]. Their expression has also been reported in cell types that are traditionally regarded as non-excitable, including glia, human vascular endothelial cells, human epidermal keratinocytes, and carcinoma cells, where their role is less clear [<xref ref-type="bibr" rid="CR50">50</xref>–<xref ref-type="bibr" rid="CR55">55</xref>]. Aberrant functional expression/activity of VGSCs has been identified as a major contributing factor in a number of human pathologies, including cardiac arrhythmia [<xref ref-type="bibr" rid="CR55">55</xref>], epilepsy [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>], pain [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>], periodic paralysis [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>], migraine [<xref ref-type="bibr" rid="CR63">63</xref>], MS [<xref ref-type="bibr" rid="CR64">64</xref>], and cancer [<xref ref-type="bibr" rid="CR65">65</xref>]. VGSCs exist as heteromeric membrane-bound protein complexes that typically consist of a single pore-forming α subunit in association with one or more β subunits [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR67">67</xref>].</p>
<p>The mammalian sodium channels include ten members (Nav1.1–Nav1.9 and Nax) encoded by genes SCN1A–SCN11A. While substantial homology exists between the isoforms, differences in amino acid sequence confer distinct voltage dependence, kinetic and pharmacological properties on each of the isotypes [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. Data concerning the location and function of each VGSCs subunit are included in Table <xref ref-type="table" rid="Tab1">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Voltage-gated sodium channels (VGSCs)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Protein</th><th align="left">Human gene</th><th align="left">Location</th><th align="left">Function</th></tr></thead><tbody><tr><td align="left" colspan="4">(A) The α subunits</td></tr><tr><td align="left">Na<sub>v</sub>1.1</td><td align="left">
<italic>SCN1A</italic>
</td><td align="left">CNS, PNS, heart</td><td align="left">CBH, dementia [<xref ref-type="bibr" rid="CR70">70</xref>], Dravet syndrome [<xref ref-type="bibr" rid="CR71">71</xref>], epilepsy [<xref ref-type="bibr" rid="CR71">71</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]</td></tr><tr><td align="left">Na<sub>v</sub>1.2</td><td align="left">
<italic>SCN2A</italic>
</td><td align="left">CNS, PNS</td><td align="left">CBH, dementia [<xref ref-type="bibr" rid="CR70">70</xref>], epilepsy [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>], autism [<xref ref-type="bibr" rid="CR74">74</xref>]</td></tr><tr><td align="left">Na<sub>v</sub>1.3</td><td align="left">
<italic>SCN3A</italic>
</td><td align="left">CNS, PNS</td><td align="left">Diabetes [<xref ref-type="bibr" rid="CR75">75</xref>], neuropathic pain [<xref ref-type="bibr" rid="CR76">76</xref>–<xref ref-type="bibr" rid="CR78">78</xref>]</td></tr><tr><td align="left">Na<sub>v</sub>1.4</td><td align="left">
<italic>SCN4A</italic>
</td><td align="left">Skeletal muscle, heart</td><td align="left">Brugada syndrome [<xref ref-type="bibr" rid="CR79">79</xref>], myotonia, periodic paralysis [<xref ref-type="bibr" rid="CR80">80</xref>]</td></tr><tr><td align="left">Na<sub>v</sub>1.5</td><td align="left">
<italic>SCN5A</italic>
</td><td align="left">Uninnervated skeletal muscle, heart, brain</td><td align="left">Breast cancer [<xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR82">82</xref>], arrhythmia [<xref ref-type="bibr" rid="CR83">83</xref>], Brugada syndrome [<xref ref-type="bibr" rid="CR84">84</xref>], angiogenic disorders [<xref ref-type="bibr" rid="CR85">85</xref>]</td></tr><tr><td align="left">Na<sub>v</sub>1.6</td><td align="left">
<italic>SCN8A</italic>
</td><td align="left">CNS, PNS, heart</td><td align="left">Epilepsy [<xref ref-type="bibr" rid="CR86">86</xref>], cervical cancer [<xref ref-type="bibr" rid="CR87">87</xref>]</td></tr><tr><td align="left">Na<sub>v</sub>1.7</td><td align="left">
<italic>SCN9A</italic>
</td><td align="left">PNS, neuroendocrine cells, sensory neurons</td><td align="left">Angiogenic disorders [<xref ref-type="bibr" rid="CR85">85</xref>], paroxysmal extreme pain disorder [<xref ref-type="bibr" rid="CR88">88</xref>]</td></tr><tr><td align="left">Na<sub>v</sub>1.8</td><td align="left">
<italic>SCN10A</italic>
</td><td align="left">Sensory neurons</td><td align="left">Prostate cancer [<xref ref-type="bibr" rid="CR89">89</xref>], cardiac arrhythmia [<xref ref-type="bibr" rid="CR90">90</xref>], MS [<xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR91">91</xref>]</td></tr><tr><td align="left">Na<sub>v</sub>1.9</td><td align="left">
<italic>SCN11A</italic>
</td><td align="left">Sensory neurons</td><td align="left">Congenital insensitivity [<xref ref-type="bibr" rid="CR92">92</xref>], cold-aggravated pain [<xref ref-type="bibr" rid="CR93">93</xref>]</td></tr><tr><td align="left">Na<sub>x</sub>
</td><td align="left">
<italic>SCN6A, SCN7A</italic>
</td><td align="left">Heart, uterus, skeletal muscle, astrocytes, DRG</td><td align="left">Atopic dermatitis [<xref ref-type="bibr" rid="CR94">94</xref>], hypertension [<xref ref-type="bibr" rid="CR95">95</xref>]</td></tr><tr><td align="left" colspan="4">(B) The β subunits</td></tr><tr><td align="left">β1</td><td align="left">
<italic>SCN1B</italic>
</td><td align="left">Heart, skeletal muscle, CNS, glia, PNS</td><td align="left">Epilepsy [<xref ref-type="bibr" rid="CR96">96</xref>], cardiac arrhythmia [<xref ref-type="bibr" rid="CR97">97</xref>], cancer [<xref ref-type="bibr" rid="CR98">98</xref>]</td></tr><tr><td align="left">β1A(β1B)</td><td align="left">
<italic>SCN1B</italic>
</td><td align="left">Heart, skeletal muscle, adrenal gland, PNS</td><td align="left">Epilepsy [<xref ref-type="bibr" rid="CR96">96</xref>]</td></tr><tr><td align="left">β2</td><td align="left">
<italic>SCN2B</italic>
</td><td align="left">CNS, PNS, heart, glia</td><td align="left">Altered pain response [<xref ref-type="bibr" rid="CR59">59</xref>], MS [<xref ref-type="bibr" rid="CR99">99</xref>]</td></tr><tr><td align="left">β3</td><td align="left">
<italic>SCN3B</italic>
</td><td align="left">CNS, adrenal gland, kidney, PNS</td><td align="left">Cancer [<xref ref-type="bibr" rid="CR98">98</xref>]</td></tr><tr><td align="left">β4</td><td align="left">
<italic>SCN4B</italic>
</td><td align="left">Heart, skeletal muscle, CNS, PNS</td><td align="left">Huntington’s disease [<xref ref-type="bibr" rid="CR100">100</xref>]</td></tr></tbody></table><table-wrap-foot><p>
<italic>CNS</italic> central nervous system, <italic>MS</italic> multiple sclerosis, <italic>PNS</italic> peripheral nervous system, <italic>CBH</italic> chronic brain hypoperfusion</p></table-wrap-foot></table-wrap>
</p>
<p>β subunits (β1–β4) combine in vivo with either β1 or β3 through non-covalent bonding and with either β2 or β4 via a covalent bond [<xref ref-type="bibr" rid="CR101">101</xref>–<xref ref-type="bibr" rid="CR104">104</xref>]. Numerous studies have revealed the presence of Na<sub>v</sub>1.1, Na<sub>v</sub>1.2, Na<sub>v</sub>1.3 [<xref ref-type="bibr" rid="CR105">105</xref>], Na<sub>v</sub>1.6 [<xref ref-type="bibr" rid="CR106">106</xref>], and Na<sub>v</sub>1.5 [<xref ref-type="bibr" rid="CR107">107</xref>] in rodent astrocytes. Sodium channels in these glial cells are localized to the plasma membrane, where they mediate sodium currents [<xref ref-type="bibr" rid="CR108">108</xref>]. The star-shaped glial cells situated in the CNS take an essential part in the response of the CNS to injury, including inflammation and degeneration in MS. Herzog et al. have shown that VGSCs can contribute to axonal injury in MS by providing a pathway for sustained sodium influx that drives the Na<sup>+</sup>/Ca<sup>2+</sup> exchanger to import calcium into axons [<xref ref-type="bibr" rid="CR109">109</xref>]. Elevated calcium levels can activate nitric oxide synthase and deleterious proteolytic enzymes [<xref ref-type="bibr" rid="CR109">109</xref>–<xref ref-type="bibr" rid="CR112">112</xref>]. The harmful effects of nitric oxide on mitochondrial function include a reduction in adenosine triphosphate (ATP) levels and an exhaustion of sodium–potassium adenosine triphosphatase (Na<sup>+</sup>K<sup>+</sup>-ATPase), hence compromising the axons’ capacity to maintain normal transmembrane sodium gradient. This action provides a positive feedback loop that imports even more intracellular calcium, thereby further enhancing the damage [<xref ref-type="bibr" rid="CR113">113</xref>]. Consequently, these mechanisms lead to axonal injury and further to disability (Fig. <xref ref-type="fig" rid="Fig1">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Positive feedback loop of Na/Ca influx to the neuron cell with a potential damaging effect in multiple sclerosis (<italic>VGSC</italic> voltage-gated sodium channel, <italic>NO</italic> nitric oxide, <italic>ATP</italic> adenosine triphosphate, Na<sup>+</sup>K<sup>+</sup>-ATPase sodium–potassium adenosine triphosphatase)</p></caption><graphic id="MO1" xlink:href="10072_2016_2802_Fig1_HTML"></graphic></fig>
</p>
<p>Numerous studies have shown that partial blockade of voltage-gated sodium channels could result in neuroprotection in patients with MS [<xref ref-type="bibr" rid="CR112">112</xref>]. Indeed, the axonal protection has been demonstrated in animals with experimental autoimmune encephalomyelitis (EAE) by means of the sodium channel blocking drugs flecainide [<xref ref-type="bibr" rid="CR114">114</xref>, <xref ref-type="bibr" rid="CR115">115</xref>], safinamide [<xref ref-type="bibr" rid="CR115">115</xref>], phenytoin [<xref ref-type="bibr" rid="CR116">116</xref>], and, recently, lamotrigine [<xref ref-type="bibr" rid="CR117">117</xref>]. Neuroprotection is emerging as a potentially important strategy for preventing disability progression in MS [<xref ref-type="bibr" rid="CR118">118</xref>]. In contrast, some clinical studies do not support the protective role of VGSC blockers in MS. Counihan et al. studied 400 patients, 51 of whom received CBZ symptomatic therapy (average duration of therapy was 27 months), and showed that the long term exposure to the VGSC-blocking drug CBZ does not affect the long-term disability and disease progression in MS patients, despite studies in animals suggesting a neuroprotective role of VGSC blockers [<xref ref-type="bibr" rid="CR119">119</xref>]. Furthermore, using CSF neurofilament (NfH) as a good surrogate marker of neurodegeneration in MS, Gnanapavan et al. revealed no benefit of lamotrigine in the prevention of axonal breakdown by lowering NfH levels compared to the placebo arm [<xref ref-type="bibr" rid="CR120">120</xref>]. The protective role of lamotrigine is also disputed by Kapoor et al. [<xref ref-type="bibr" rid="CR121">121</xref>], but it is premature to fully dismiss this hypothesis.</p>
</sec>
<sec id="Sec6">
<title>Sodium chloride intake and MS</title>
<p>High intake of sodium chloride is currently considered to be a potentially important factor influencing the onset of MS. Changes in eating habits that have occurred in recent decades in developed countries may account for an increase in incidence of MS and other autoimmune diseases [<xref ref-type="bibr" rid="CR122">122</xref>]. Today’s typical Western diet includes more sodium chloride than it was in the past [<xref ref-type="bibr" rid="CR123">123</xref>]. Therefore, popular processed meals, such as “fast food”, contain approximately 100 times more sodium chloride than homemade meals [<xref ref-type="bibr" rid="CR124">124</xref>, <xref ref-type="bibr" rid="CR125">125</xref>]. Increased hypertonicity can stimulate the immune system [<xref ref-type="bibr" rid="CR126">126</xref>], and furthermore, superior sodium chloride uptake can affect the innate immune system [<xref ref-type="bibr" rid="CR127">127</xref>].</p>
<p>Recent studies have demonstrated the importance of interleukin-17 (IL-17)-induced CD4+ Th17 cell population in autoimmune diseases [<xref ref-type="bibr" rid="CR128">128</xref>]. Kleinewietfield et al. showed that the addition of a modest amount of NaCl (40 mM) to a culture of differentiating Th17 cells caused a roughly logarithmic augmentation of IL-17A in naïve CD4 cells in vitro and this process was mediated by p38/MAPK, NFAT5, and SGK [<xref ref-type="bibr" rid="CR122">122</xref>]. Moreover, high-salt concentration results in growth of pathogenic phenotype of Th17 cells [<xref ref-type="bibr" rid="CR122">122</xref>, <xref ref-type="bibr" rid="CR129">129</xref>, <xref ref-type="bibr" rid="CR130">130</xref>]. Thus, the change in eating habits that includes a high amount of salt may contribute to the recent increase in MS incidence through the induction of pathogenic Th17 cells [<xref ref-type="bibr" rid="CR122">122</xref>, <xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR128">128</xref>]. The Th17 cells induced by high-salt concentration upregulate the production of pro-inflammatory cytokines GM-CSF, TNFα, IL-2, IL-9, several chemokines [<xref ref-type="bibr" rid="CR131">131</xref>, <xref ref-type="bibr" rid="CR132">132</xref>], and CCR6 [<xref ref-type="bibr" rid="CR133">133</xref>], which are essential for the autoimmune function of Th17 cells. Higher Na<sup>+</sup> concentration, such as that between 160 and 250 mM, in the interstitium and lymphoid tissue and significantly lower concentration of Na<sup>+</sup> in plasma, approximately 140 mM, are likely to be the mechanism for decreasing the inflammatory response in the blood while favoring immune activation in lymphoid tissues or with migration of cells into tissue [<xref ref-type="bibr" rid="CR127">127</xref>, <xref ref-type="bibr" rid="CR134">134</xref>]. Otherwise, diet rich in salt can affect the severity of the disease. Kleinewietfeld et al. showed that mice fed salty meals developed deterioration of EAE, with an increase in Th17 cell number and augmented infiltration of Th17 cells into the CNS [<xref ref-type="bibr" rid="CR122">122</xref>]. Moreover, in an observational trial on 122 MS patients, Farez et al. demonstrated that the disease exacerbation rate was 2.75-fold in participants with medium salt intake (2–4.8 g/day) (95% CI 1.3–5.8) and 9.95-fold in participants with high sodium intake (4.8 g/day or more) (95% CI 1.4–11.2) compared with the low-intake group (under 2 g/day) [<xref ref-type="bibr" rid="CR135">135</xref>]. This finding may be due to the fact that sodium concentration is tightly regulated within narrow limits regardless of large variations in sodium consumption, due to its importance in general metabolism [<xref ref-type="bibr" rid="CR136">136</xref>]. The renin–angiotensin–aldosterone system (RAAS), which is a major regulator of blood pressure, also significantly affects autoimmunity in many diseases which include MS and its animal model—EAE. Han et al. showed that peptides related to the RAAS are present in CNS lesions of MS patients [<xref ref-type="bibr" rid="CR137">137</xref>]. Sodium chloride, among many other physiological effects, modulates the renin–angiotensin system [<xref ref-type="bibr" rid="CR138">138</xref>]. Interestingly, the activation of renin and angiotensin has been implicated in the pathogenesis of EAE [<xref ref-type="bibr" rid="CR139">139</xref>]. Furthermore, increases in systolic blood pressure similar to those observed with high-salt consumption have recently been shown to be associated with the disruption of white matter integrity in young normotensive individuals [<xref ref-type="bibr" rid="CR140">140</xref>]. In addition, Platten et al. demonstrated an increase in the expression of angiotensin receptor 1 (AT1R) in lymph node cells, indicating that AT1R is activated in antigen-specific T cells during the peripheral immune response to autoantigens. In addition, angiotensin II (AII) binding was augmented in Periodate–Lysine–Paraformaldehyde (PLP)-activated CD4 + T cells and to a lesser extent in activated CD11b + monocytes. Immunization with PLP139–151 led to an induction of AII in CD4 + T cells, CD11b + monocytes, and to an increase in serum AII levels, demonstrating that the RAAS is activated in peripheral immune cells. Pretreatment of mice immunized with PLP139–151 with the angiotensin converting enzyme (ACE) inhibitor lisinopril {N2-[(S)-1-carboxy-3-phenylpropyl]-L-lysyl-<sc>l</sc>-proline} or the AT1R antagonist candesartan (3-{[2′-(2 H -tetrazol-5-yl)biphenyl-4-yl]methyl}-2-ethoxy-3 H -benzo[d]imidazole-4-carboxylic acid) resulted in suppression of Th1 and Th17 cytokine release and up-regulation of immunosuppressive cytokines, such as IL-10 and transforming growth factor-β (TGF-β) [<xref ref-type="bibr" rid="CR141">141</xref>]. Probable impact of high sodium diet on immune functions in MS patients was presented in Fig. <xref ref-type="fig" rid="Fig2">2</xref>.<fig id="Fig2"><label>Fig. 2</label><caption><p>Probable impact of high sodium diet on immune functions in multiple sclerosis patients (<italic>CNS</italic> central nervous system, <italic>RAAS</italic> renin–angiotensin–aldosterone system)</p></caption><graphic id="MO2" xlink:href="10072_2016_2802_Fig2_HTML"></graphic></fig>
</p>
<p>Hucke et al. revealed a multidirectional activity of sodium chloride-rich diet in both humans and mice. Sodium chloride-rich diet promotes CNS autoimmunity, increases macrophage responses, skews the balance towards a pro-inflammatory M1 phenotype in macrophages, alters MAPK signaling in macrophages, and induces a pro-inflammatory phenotype in human monocytes [<xref ref-type="bibr" rid="CR142">142</xref>]. In addition, Yi et al. demonstrated that high-salt intake promotes an increase in human serum monocytes, which play a pivotal role in the development of various immunological diseases [<xref ref-type="bibr" rid="CR143">143</xref>]. Furthermore, Jörg et al. showed that a high-salt diet in the early phase of neuroinflammation mainly acts on Th17 cells and is independent of myeloid cells. This finding can help elucidate the impact of a high-salt diet on the emergence and course of autoimmune diseases [<xref ref-type="bibr" rid="CR144">144</xref>]. Krementsov et al. demonstrated an increase in blood–brain barrier permeability and brain pathology in mice as a consequence of a high-salt diet, but did not demonstrate augmentation of Th17 or Th1 responses. Moreover, this study showed that the effects of dietary sodium on autoimmune neuroinflammation are sex-specific, genetically dependent, and CNS-mediated [<xref ref-type="bibr" rid="CR145">145</xref>]. Furthermore, Zhou et al. demonstrated that a short-term increase in dietary salt intake could induce the expansion of CD14++CD16+ monocytes, as well as an increase in monocyte platelet aggregates (MPAs), which might be the cellular basis of high-salt-induced end organ inflammation and potential thromboembolic risk, independent of changes in blood pressure [<xref ref-type="bibr" rid="CR146">146</xref>]. In addition, Hernandez et al. reported that excess dietary sodium intake lowers immunosuppressive actions of human and murine Foxp3+ Tregs in vitro and in vivo and is associated with increased Treg IFNγ secretion in vivo [<xref ref-type="bibr" rid="CR147">147</xref>]. Data concerning the immunological effects of sodium chloride intake are shown in Table <xref ref-type="table" rid="Tab2">2</xref>.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Immunological effects of sodium chloride intake</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Examined subjects</th><th align="left">Time (days)</th><th align="left">Sodium intake</th><th align="left">Observed effects</th><th align="left"></th></tr></thead><tbody><tr><td align="left">C57BL/6J mice</td><td align="left">20</td><td align="left">Na<sup>+</sup>-rich diet</td><td align="left">Increase in Th17 cells proliferation<break></break>Exacerbation of EAE</td><td align="left">[<xref ref-type="bibr" rid="CR121">121</xref>]</td></tr><tr><td align="left">Human and rabbit PBMC</td><td align="left">–</td><td align="left">Na<sup>+</sup> hipertonic medium 25–30 mM (in vitro)</td><td align="left">T cell proliferation was doubled in 25 mM medium<break></break>Increased hypertonicity (&gt;40 mM in human cells; &gt;80 mM in rabbit cells) caused progressive Suppression of proliferation<break></break>monocyte functions augmentation</td><td align="left">[<xref ref-type="bibr" rid="CR126">126</xref>]</td></tr><tr><td align="left">Cd4 Cre Sgk1 fl/fl mice and WT mice</td><td align="left">21</td><td align="left">High-salt diet</td><td align="left">Increase in EAE severity in WT mice, but not in SGK1-deficient mice<break></break>Increase of Th17 cells in mLN and CNS of WT mice, but not in SGK1-deficient mice<break></break>Increase in IFN production by T cells in the CNS in WT mice<break></break>Increase in IL-17 synthesis by CD4+ T cells</td><td align="left">[<xref ref-type="bibr" rid="CR130">130</xref>]</td></tr><tr><td align="left">RRMS patients</td><td align="left">720</td><td align="left">Dietary 2–4.8 g/day of Na<sup>+</sup> intake</td><td align="left">Increase in exacerbation rate (2–4 fold) in patients with medium or high sodium diet<break></break>Increase in the risk of developing a new MRI lesions in high Na<sup>+</sup> diet patients</td><td align="left">[<xref ref-type="bibr" rid="CR135">135</xref>]</td></tr><tr><td align="left">C57BL/6J mice</td><td align="left">50</td><td align="left">Na<sup>+</sup>-rich diet</td><td align="left">Increase in murine Th17 and Th1 cells<break></break>Increase in IL-17A and IFN-γ secretion</td><td align="left">[<xref ref-type="bibr" rid="CR144">144</xref>]</td></tr><tr><td align="left">C57BL6/J mice and SJL/JCrHsd mice</td><td align="left">–</td><td align="left">High-salt diet</td><td align="left">Exacerbation of disease in M and F of C57BL6/J mice but only in F of SJL/JCrHsd mice<break></break>No influence on C57BL6/J mice carrying a 129/Sv-derived interval on chromosome 17<break></break>No influence on Th17 or Th1 cells<break></break>Increase in blood–brain barrier permeability and brain pathologies</td><td align="left">[<xref ref-type="bibr" rid="CR145">145</xref>]</td></tr><tr><td align="left">
<italic>Foxp3</italic>-GFP reporter mice</td><td align="left">21</td><td align="left">Na<sup>+</sup>-rich diet</td><td align="left">Induction of Th1-type phenotype<break></break>Impairement in Treg function (IFNγ-dependent)</td><td align="left">[<xref ref-type="bibr" rid="CR147">147</xref>]</td></tr><tr><td align="left">Healthy human</td><td align="left">205</td><td align="left">Dietary NaCl reduction</td><td align="left">Decrease in monocytes counts<break></break>Decrease in IL-6 (30%), IL-23 (90%) and IL-17 concentration<break></break>Increase in IL-10 level (threefold)<break></break>Slightly decrease in VEGF-C serum concentration</td><td align="left"></td></tr><tr><td align="left">Healthy human</td><td align="left">17</td><td align="left">High-to-low NaCl diet</td><td align="left">Increase in CD14++ and CD16+ monocytes proliferation<break></break>Increase in intracellular ROS production</td><td align="left"></td></tr></tbody></table><table-wrap-foot><p>
<italic>EAE</italic> experimental autoimmune encephalomyelitis, <italic>PBMC</italic> peripheral blood mononuclear cells, <italic>ROS</italic> reactive oxygen species</p></table-wrap-foot></table-wrap>
</p>
<p>In conclusion, recent reports have demonstrated a potential pro-inflammatory role of excess sodium chloride intake in the pathogenesis of autoimmune and neurodegenerative diseases, both in vitro and in vivo, although the outcomes of these studies are not unanimous. Nevertheless, the current knowledge suggests that a low-salt diet (&lt;5 g/day) might be beneficial in the prevention and treatment of autoimmune diseases, including MS.</p>
</sec>
</body>
<back>
<notes notes-type="COI-statement">
<title>Compliance with ethical standards</title>
<sec id="FPar1">
<title>Conflict of interest</title>
<p>The authors report no conflict of interest. The authors alone are responsible for the content and writing of this paper.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moghadasi</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Pourmand</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sharifian</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Behavioral neurology of multiple sclerosis and autoimmune encephalopathies</article-title>
<source/>Neurol Clin
          <year>2016</year>
<volume>34</volume>
<issue>1</issue>
<fpage>17</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="pmid">26613993</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mandia</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ferraro</surname>
<given-names>OE</given-names>
</name>
<name>
<surname>Nosari</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Environmental factors and multiple sclerosis severity: a descriptive study</article-title>
<source/>Int J Environ Res Public Health
          <year>2014</year>
<volume>11</volume>
<issue>6</issue>
<fpage>6417</fpage>
<lpage>6432</lpage>
<pub-id pub-id-type="pmid">24950063</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ascherio</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Munger</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Lennette</surname>
<given-names>ET</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study</article-title>
<source/>JAMA
          <year>2001</year>
<volume>286</volume>
<issue>24</issue>
<fpage>3083</fpage>
<lpage>3088</lpage>
<pub-id pub-id-type="pmid">11754673</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farrell</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Antony</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wall</surname>
<given-names>GR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI</article-title>
<source/>Neurology
          <year>2009</year>
<volume>73</volume>
<issue>1</issue>
<fpage>32</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="pmid">19458321</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramroodi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Niazi</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Sanadgol</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evaluation of reactive Epstein-Barr Virus (EBV) in Iranian patient with different subtypes of multiple sclerosis (MS)</article-title>
<source/>Braz J Infect Dis
          <year>2013</year>
<volume>17</volume>
<issue>2</issue>
<fpage>156</fpage>
<lpage>163</lpage>
<pub-id pub-id-type="pmid">23465600</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pierrot-Deseilligny</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Clinical implications of a possible role of vitamin D in multiple sclerosis</article-title>
<source/>J Neurol
          <year>2009</year>
<volume>256</volume>
<issue>9</issue>
<fpage>1468</fpage>
<lpage>1479</lpage>
<pub-id pub-id-type="pmid">19399382</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cline</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Calcium and vitamin d metabolism, deficiency, and excess</article-title>
<source/>Top Companion Anim Med
          <year>2012</year>
<volume>27</volume>
<issue>4</issue>
<fpage>159</fpage>
<lpage>164</lpage>
<pub-id pub-id-type="pmid">23415383</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holmøy</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Torkildsen</surname>
<given-names>Ø</given-names>
</name>
<name>
<surname>Myhr</surname>
<given-names>KM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore</article-title>
<source/>Acta Neurol Scand Suppl
          <year>2012</year>
<volume>195</volume>
<fpage>63</fpage>
<lpage>69</lpage>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steffensen</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Brustad</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kampman</surname>
<given-names>MT</given-names>
</name>
</person-group>
<article-title>What is needed to keep persons with multiple sclerosis vitamin D-sufficient throughout the year?</article-title>
<source/>J Neurol
          <year>2013</year>
<volume>260</volume>
<issue>1</issue>
<fpage>182</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="pmid">22850935</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kampman</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Steffensen</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Mellgren</surname>
<given-names>SI</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial</article-title>
<source/>Mult Scler
          <year>2012</year>
<volume>18</volume>
<issue>8</issue>
<fpage>1144</fpage>
<lpage>1151</lpage>
<pub-id pub-id-type="pmid">22354743</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stein</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>OM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis</article-title>
<source/>Neurology
          <year>2011</year>
<volume>77</volume>
<issue>17</issue>
<fpage>1611</fpage>
<lpage>1618</lpage>
<pub-id pub-id-type="pmid">22025459</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hedström</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Olsson</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Alfredsson</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Smoking is a major preventable risk factor for multiple sclerosis</article-title>
<source/>Mult Scler
          <year>2016</year>
<volume>22</volume>
<issue>8</issue>
<fpage>1021</fpage>
<lpage>1026</lpage>
<pub-id pub-id-type="pmid">26459151</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramanujam</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hedström</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Manouchehrinia</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effect of smoking cessation on multiple sclerosis prognosis</article-title>
<source/>JAMA Neurol
          <year>2015</year>
<volume>72</volume>
<issue>10</issue>
<fpage>1117</fpage>
<lpage>1123</lpage>
<pub-id pub-id-type="pmid">26348720</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kvistad</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Myhr</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Holmøy</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Body mass index influence interferon-betatreatment response in multiple sclerosis</article-title>
<source/>J Neuroimmunol
          <year>2015</year>
<volume>288</volume>
<fpage>92</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="pmid">26531700</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sloka</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pryse-Phillips</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A quantitative analysis of suspected environmental causes of MS</article-title>
<source/>Can J Neurol Sci
          <year>2011</year>
<volume>38</volume>
<issue>1</issue>
<fpage>98</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="pmid">21156437</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bäärnhielm</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hedström</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Kockum</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15</article-title>
<source/>Eur J Neurol
          <year>2012</year>
<volume>19</volume>
<issue>7</issue>
<fpage>955</fpage>
<lpage>962</lpage>
<pub-id pub-id-type="pmid">22289117</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marrie</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Environmental risk factors in multiple sclerosis aetiology</article-title>
<source/>Lancet Neurol
          <year>2004</year>
<volume>3</volume>
<issue>12</issue>
<fpage>709</fpage>
<lpage>718</lpage>
<pub-id pub-id-type="pmid">15556803</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pugliatti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sotgiu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rosati</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>The worldwide prevalence of multiple sclerosis</article-title>
<source/>Clin Neurol Neurosurg
          <year>2002</year>
<volume>104</volume>
<issue>3</issue>
<fpage>182</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="pmid">12127652</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Munger</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Levin</surname>
<given-names>LI</given-names>
</name>
<name>
<surname>O’Reilly</surname>
<given-names>EJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel</article-title>
<source/>Mult Scler
          <year>2011</year>
<volume>17</volume>
<issue>10</issue>
<fpage>1185</fpage>
<lpage>1193</lpage>
<pub-id pub-id-type="pmid">21685232</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Villoslada</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Juste</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tintore</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The immune response against herpesvirus is more prominent in the early stages of MS</article-title>
<source/>Neurology
          <year>2003</year>
<volume>60</volume>
<issue>12</issue>
<fpage>1944</fpage>
<lpage>1948</lpage>
<pub-id pub-id-type="pmid">12821737</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yea</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tellier</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Chong</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Canadian pediatric demyelinating disease network. Epstein-Barr virus in oral shedding of children with multiple sclerosis</article-title>
<source/>Neurology
          <year>2013</year>
<volume>81</volume>
<issue>16</issue>
<fpage>1392</fpage>
<lpage>1399</lpage>
<pub-id pub-id-type="pmid">24014504</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buljevac</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Flach</surname>
<given-names>HZ</given-names>
</name>
<name>
<surname>Hop</surname>
<given-names>WC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prospective study on the relationship between infections and multiple sclerosis exacerbations</article-title>
<source/>Brain
          <year>2002</year>
<volume>125</volume>
<issue>Pt5</issue>
<fpage>952</fpage>
<lpage>960</lpage>
<pub-id pub-id-type="pmid">11960885</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Versini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jeandel</surname>
<given-names>PY</given-names>
</name>
<name>
<surname>Rosenthal</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Obesity in autoimmune diseases: not a passive bystander</article-title>
<source/>Autoimmun Rev
          <year>2014</year>
<volume>13</volume>
<issue>9</issue>
<fpage>981</fpage>
<lpage>1000</lpage>
<pub-id pub-id-type="pmid">25092612</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Adipocytokines in obesity and metabolic disease</article-title>
<source/>J Endocrinol
          <year>2014</year>
<volume>220</volume>
<issue>2</issue>
<fpage>T47</fpage>
<lpage>T59</lpage>
<pub-id pub-id-type="pmid">24403378</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveira</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Simão</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Kallaur</surname>
<given-names>AP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disability in patients with multiple sclerosis: influence of insulin resistance, adiposity, and oxidative stress</article-title>
<source/>Nutrition
          <year>2014</year>
<volume>30</volume>
<issue>3</issue>
<fpage>268</fpage>
<lpage>273</lpage>
<pub-id pub-id-type="pmid">24484677</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simpson</surname>
<given-names>S</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Blizzard</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Otahal</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis</article-title>
<source/>J Neurol Neurosurg Psychiatry
          <year>2011</year>
<volume>82</volume>
<issue>10</issue>
<fpage>1132</fpage>
<lpage>1141</lpage>
<pub-id pub-id-type="pmid">21478203</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harbo</surname>
<given-names>HF</given-names>
</name>
<name>
<surname>Utsi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lorentzen</surname>
<given-names>AR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami</article-title>
<source/>Tissue Antigens
          <year>2007</year>
<volume>69</volume>
<issue>4</issue>
<fpage>299</fpage>
<lpage>304</lpage>
<pub-id pub-id-type="pmid">17389012</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kingwell</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Marriott</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Jetté</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Incidence and prevalence of multiple sclerosis in Europe: a systematic review</article-title>
<source/>BMC Neurol
          <year>2013</year>
<volume>13</volume>
<fpage>128</fpage>
<pub-id pub-id-type="pmid">24070256</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kantarci</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Wingerchuk</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Epidemiology and natural history of multiple sclerosis: new insights</article-title>
<source/>Curr Opin Neurol
          <year>2006</year>
<volume>19</volume>
<issue>3</issue>
<fpage>248</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="pmid">16702830</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coo</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Aronson</surname>
<given-names>KJ</given-names>
</name>
</person-group>
<article-title>A systematic review of several potential non-genetic risk factors for multiple sclerosis</article-title>
<source/>Neuroepidemiology
          <year>2004</year>
<volume>23</volume>
<issue>1–2</issue>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="pmid">14739563</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smolders</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Damoiseaux</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Menheere</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Vitamin D as an immune modulator in multiple sclerosis, a review</article-title>
<source/>J Neuroimmunol
          <year>2008</year>
<volume>194</volume>
<issue>1–2</issue>
<fpage>7</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="pmid">18177949</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pantzaris</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Loukaides</surname>
<given-names>GN</given-names>
</name>
<name>
<surname>Ntzani</surname>
<given-names>EE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial</article-title>
<source/>BMJ Open
          <year>2013</year>
<volume>3</volume>
<issue>4</issue>
<fpage>e002170</fpage>
<pub-id pub-id-type="pmid">23599375</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torkildsen</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Wergeland</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bakke</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial</article-title>
<source/>Arch Neurol
          <year>2012</year>
<volume>69</volume>
<issue>8</issue>
<fpage>1044</fpage>
<lpage>1051</lpage>
<pub-id pub-id-type="pmid">22507886</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khalili</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Azimi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Izadi</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Does lipoic acid consumption affect the cytokine profile in multiple sclerosis patients: a double-blind, placebo-controlled, randomized clinical trial</article-title>
<source/>Neuroimmunomodulation
          <year>2014</year>
<volume>21</volume>
<issue>6</issue>
<fpage>291</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="pmid">24821457</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vergelli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Olivotto</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Castigli</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunosuppressive activity of 13-cis-retinoic acid in rats: aspects of pharmacokinetics and pharmacodynamics</article-title>
<source/>Immunopharmacology
          <year>1997</year>
<volume>37</volume>
<issue>2–3</issue>
<fpage>191</fpage>
<lpage>197</lpage>
<pub-id pub-id-type="pmid">9403338</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hall</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Grainger</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>SP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The role of retinoic acid in tolerance and immunity</article-title>
<source/>Immunity
          <year>2011</year>
<volume>35</volume>
<issue>1</issue>
<fpage>13</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="pmid">21777796</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bitarafan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Saboor-Yaraghi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sahraian</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effect of vitamin A supplementation on fatigue and depression in multiple sclerosis patients: a double-blind placebo-controlled clinical trial</article-title>
<source/>Iran J Allergy Asthma Immunol
          <year>2016</year>
<volume>15</volume>
<issue>1</issue>
<fpage>13</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="pmid">26996107</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Storoni</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Plant</surname>
<given-names>GT</given-names>
</name>
</person-group>
<article-title>The therapeutic potential of the ketogenic diet in treating progressive multiple sclerosis</article-title>
<source/>Mult Scler Int
          <year>2015</year>
<volume>2015</volume>
<fpage>681289</fpage>
<pub-id pub-id-type="pmid">26839705</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allen</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Bhatia</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>CM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ketogenic diets as an adjuvant cancer therapy: history and potential mechanism</article-title>
<source/>Redox Biol
          <year>2014</year>
<volume>2</volume>
<fpage>963</fpage>
<lpage>970</lpage>
<pub-id pub-id-type="pmid">25460731</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim do</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis</article-title>
<source/>PLoS One
          <year>2012</year>
<volume>7</volume>
<issue>5</issue>
<fpage>e35476</fpage>
<pub-id pub-id-type="pmid">22567104</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malin</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Cotugna</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>CS</given-names>
</name>
</person-group>
<article-title>Effect of creatine supplementation on muscle capacity in individuals with multiple sclerosis</article-title>
<source/>J Diet Suppl
          <year>2008</year>
<volume>5</volume>
<issue>1</issue>
<fpage>20</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="pmid">22433042</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swank</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Goodwin</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Review of MS patient survival on a Swank low saturated fat diet</article-title>
<source/>Nutrition
          <year>2003</year>
<volume>19</volume>
<issue>2</issue>
<fpage>161</fpage>
<lpage>162</lpage>
<pub-id pub-id-type="pmid">12591551</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riccio</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rossano</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Nutrition facts in multiple sclerosis</article-title>
<source/>ASN Neuro
          <year>2015</year>
<volume>7</volume>
<issue>1</issue>
<fpage>1759091414568185</fpage>
<pub-id pub-id-type="pmid">25694551</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plemel</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Juzwik</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Benson</surname>
<given-names>CA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Over-the-counter anti-oxidant therapies for use in multiple sclerosis: a systematic review</article-title>
<source/>Mult Scler
          <year>2015</year>
<volume>21</volume>
<issue>12</issue>
<fpage>1485</fpage>
<lpage>1495</lpage>
<pub-id pub-id-type="pmid">26286700</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdolahi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yavari</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Honarvar</surname>
<given-names>NM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular mechanisms of the action of vitamin A in Th17/Treg axis in multiple sclerosis</article-title>
<source/>J Mol Neurosci
          <year>2015</year>
<volume>57</volume>
<issue>4</issue>
<fpage>605</fpage>
<lpage>613</lpage>
<pub-id pub-id-type="pmid">26319266</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bitarafan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Saboor-Yaraghi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sahraian</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impact of vitamin A supplementation on disease progression in patients with multiple sclerosis</article-title>
<source/>Arch Iran Med
          <year>2015</year>
<volume>18</volume>
<issue>7</issue>
<fpage>435</fpage>
<lpage>440</lpage>
<pub-id pub-id-type="pmid">26161708</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hille</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Ionic channels in excitable membranes. Current problems and biophysical approaches</article-title>
<source/>Biophys J
          <year>1978</year>
<volume>22</volume>
<issue>2</issue>
<fpage>283</fpage>
<lpage>294</lpage>
<pub-id pub-id-type="pmid">656545</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hodgkin</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Huxley</surname>
<given-names>AF</given-names>
</name>
</person-group>
<article-title>A quantitative description of membrane current and its application to conduction and excitation in nerve</article-title>
<source/>J Physiol
          <year>1952</year>
<volume>117</volume>
<fpage>500</fpage>
<lpage>544</lpage>
<pub-id pub-id-type="pmid">12991237</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barres</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Chun</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Corey</surname>
<given-names>DP</given-names>
</name>
</person-group>
<article-title>Ion channels in vertebrate glia</article-title>
<source/>Annu Rev Neurosci
          <year>1990</year>
<volume>13</volume>
<fpage>441</fpage>
<lpage>474</lpage>
<pub-id pub-id-type="pmid">2158266</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gautron</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dos Santos</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pinto-Henrique</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The glial voltage-gated sodium channel: cell- and tissue-specific mRNA expression</article-title>
<source/>Proc Natl Acad Sci USA
          <year>1992</year>
<volume>89</volume>
<issue>15</issue>
<fpage>7272</fpage>
<lpage>7276</lpage>
<pub-id pub-id-type="pmid">1379737</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gosling</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Harley</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>RJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human saphenous vein endothelial cells express a tetrodotoxin-resistant, voltage-gated sodium current</article-title>
<source/>J Biol Chem
          <year>1998</year>
<volume>273</volume>
<issue>33</issue>
<fpage>21084</fpage>
<lpage>21090</lpage>
<pub-id pub-id-type="pmid">9694861</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diss</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Djamgoz</surname>
<given-names>MB</given-names>
</name>
</person-group>
<article-title>Voltage-gated Na<sup>+</sup> channels: multiplicity of expression, plasticity, functional implications and pathophysiological aspects</article-title>
<source/>Eur Biophys J
          <year>2004</year>
<volume>33</volume>
<issue>3</issue>
<fpage>180</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="pmid">14963621</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Káradóttir</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>NB</given-names>
</name>
<name>
<surname>Bakiri</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Spiking and nonspiking classes of oligodendrocyte precursor glia in CNS white matter</article-title>
<source/>Nat Neurosci
          <year>2008</year>
<volume>11</volume>
<issue>4</issue>
<fpage>450</fpage>
<lpage>456</lpage>
<pub-id pub-id-type="pmid">18311136</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Barr</surname>
<given-names>TP</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>Q</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Voltage-gated sodium channel expression in rat and human epidermal keratinocytes: evidence for a role in pain</article-title>
<source/>Pain
          <year>2008</year>
<volume>139</volume>
<issue>1</issue>
<fpage>90</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="pmid">18442883</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopez-Santiago</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Meadows</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Ernst</surname>
<given-names>SJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals</article-title>
<source/>J Mol Cell Cardiol
          <year>2007</year>
<volume>43</volume>
<fpage>636</fpage>
<lpage>647</lpage>
<pub-id pub-id-type="pmid">17884088</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wallace</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Febrile seizures and generalized epilepsy associated with a mutation in the Na<sup>+</sup>-channel beta1 subunit gene SCN1B</article-title>
<source/>Nat Genet
          <year>1998</year>
<volume>19</volume>
<fpage>366</fpage>
<lpage>370</lpage>
<pub-id pub-id-type="pmid">9697698</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Audenaert</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Claes</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ceulemans</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A deletion in SCN1B is associated with febrile seizures and early-onset absence epilepsy</article-title>
<source/>Neurology
          <year>2003</year>
<volume>61</volume>
<fpage>854</fpage>
<lpage>856</lpage>
<pub-id pub-id-type="pmid">14504340</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheffer</surname>
<given-names>IE</given-names>
</name>
<name>
<surname>Harkin</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Grinton</surname>
<given-names>BE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations</article-title>
<source/>Brain
          <year>2007</year>
<volume>130</volume>
<issue>Pt 1</issue>
<fpage>100</fpage>
<lpage>109</lpage>
<pub-id pub-id-type="pmid">17020904</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopez-Santiago</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Pertin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Morisod</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sodium channel beta2 subunits regulate tetrodotoxin-sensitive sodium channels in small dorsal root ganglion neurons and modulate the response to pain</article-title>
<source/>J Neurosci
          <year>2006</year>
<volume>26</volume>
<fpage>7984</fpage>
<lpage>7994</lpage>
<pub-id pub-id-type="pmid">16870743</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cummins</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Sheets</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Waxman</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>The roles of sodium channels in nociception: implications for mechanisms of pain</article-title>
<source/>Pain
          <year>2007</year>
<volume>131</volume>
<fpage>243</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="pmid">17766042</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fontaine</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Khurana</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Hoffman</surname>
<given-names>EP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene</article-title>
<source/>Science
          <year>1990</year>
<volume>250</volume>
<fpage>1000</fpage>
<lpage>1002</lpage>
<pub-id pub-id-type="pmid">2173143</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waxman</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>Channel, neuronal and clinical function in sodium channelopathies: from genotype to phenotype</article-title>
<source/>Nat Neurosci
          <year>2007</year>
<volume>10</volume>
<fpage>405</fpage>
<lpage>409</lpage>
<pub-id pub-id-type="pmid">17387329</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dichgans</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Freilinger</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Eckstein</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine</article-title>
<source/>Lancet
          <year>2005</year>
<volume>366</volume>
<fpage>371</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="pmid">16054936</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waxman</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>Axonal conduction and injury in multiple sclerosis: the role of sodium channels</article-title>
<source/>Nat Rev Neurosci
          <year>2006</year>
<volume>7</volume>
<fpage>932</fpage>
<lpage>941</lpage>
<pub-id pub-id-type="pmid">17115075</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fraser</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Diss</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Chioni</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis</article-title>
<source/>Clin Cancer Res
          <year>2005</year>
<volume>11</volume>
<fpage>5381</fpage>
<lpage>5389</lpage>
<pub-id pub-id-type="pmid">16061851</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brackenbury</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Isom</surname>
<given-names>LL</given-names>
</name>
</person-group>
<article-title>Voltage-gated Na<sup>+</sup> channels: potential for beta subunits as therapeutic targets</article-title>
<source/>Expert Opin Ther Targets
          <year>2008</year>
<volume>12</volume>
<issue>9</issue>
<fpage>1191</fpage>
<lpage>1203</lpage>
<pub-id pub-id-type="pmid">18694383</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brackenbury</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Djamgoz</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Isom</surname>
<given-names>LL</given-names>
</name>
</person-group>
<article-title>An emerging role for voltage-gated Na<sup>+</sup> channels in cellular migration: regulation of central nervous system development and potentiation of invasive cancers</article-title>
<source/>Neuroscientist
          <year>2008</year>
<volume>14</volume>
<issue>6</issue>
<fpage>571</fpage>
<lpage>583</lpage>
<pub-id pub-id-type="pmid">18940784</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roy</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Narahashi</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Differential properties of tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels in rat dorsal root ganglion neurons</article-title>
<source/>J Neurosci
          <year>1992</year>
<volume>12</volume>
<issue>6</issue>
<fpage>2104</fpage>
<lpage>2111</lpage>
<pub-id pub-id-type="pmid">1318956</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ikeda</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Schofield</surname>
<given-names>GG</given-names>
</name>
<name>
<surname>Weight</surname>
<given-names>FF</given-names>
</name>
</person-group>
<article-title>Na<sup>+</sup> and Ca<sup>2+</sup> currents of acutely isolated adult rat nodose ganglion cells</article-title>
<source/>J Neurophysiol
          <year>1986</year>
<volume>55</volume>
<issue>3</issue>
<fpage>527</fpage>
<lpage>539</lpage>
<pub-id pub-id-type="pmid">2420945</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>XL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MicroRNA-9 induces defective trafficking of Nav1.1 and Nav1.2 by targeting Navβ2 protein coding region in rat with chronic brain hypoperfusion</article-title>
<source/>Mol Neurodegener
          <year>2015</year>
<volume>10</volume>
<fpage>36</fpage>
<pub-id pub-id-type="pmid">26259688</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogiwara</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Miyamoto</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Morita</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation</article-title>
<source/>J Neurosci
          <year>2007</year>
<volume>27</volume>
<issue>22</issue>
<fpage>5903</fpage>
<lpage>5914</lpage>
<pub-id pub-id-type="pmid">17537961</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Catterall</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Kalume</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Oakley</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>NaV1.1 channels and epilepsy</article-title>
<source/>J Physiol
          <year>2010</year>
<volume>588</volume>
<issue>Pt 11</issue>
<fpage>1849</fpage>
<lpage>1859</lpage>
<pub-id pub-id-type="pmid">20194124</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howell</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Carvill</surname>
<given-names>GL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SCN2A encephalopathy: a major cause of epilepsy of infancy with migrating focal seizures</article-title>
<source/>Neurology
          <year>2015</year>
<volume>85</volume>
<issue>11</issue>
<fpage>958</fpage>
<lpage>966</lpage>
<pub-id pub-id-type="pmid">26291284</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gazina</surname>
<given-names>EV</given-names>
</name>
<name>
<surname>Leaw</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>KL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>‘Neonatal’ Nav1.2 reduces neuronal excitability and affects seizure susceptibility and behaviour</article-title>
<source/>Hum Mol Genet
          <year>2015</year>
<volume>24</volume>
<issue>5</issue>
<fpage>1457</fpage>
<lpage>1468</lpage>
<pub-id pub-id-type="pmid">25378553</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhalla</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ning</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Blockade of Na<sup>+</sup>channels in pancreatic α-cells has antidiabetic effects</article-title>
<source/>Diabetes
          <year>2014</year>
<volume>63</volume>
<issue>10</issue>
<fpage>3545</fpage>
<lpage>3556</lpage>
<pub-id pub-id-type="pmid">24812428</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>CH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intrathecal miR-183 delivery suppresses mechanical allodynia in mononeuropathic rats</article-title>
<source/>Eur J Neurosci
          <year>2014</year>
<volume>39</volume>
<issue>10</issue>
<fpage>1682</fpage>
<lpage>1689</lpage>
<pub-id pub-id-type="pmid">24612023</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Samad</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Dib-Hajj</surname>
<given-names>SD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Virus-mediated knockdown of Nav1.3 in dorsal root ganglia of STZ-induced diabetic rats alleviates tactile allodynia</article-title>
<source/>Mol Med
          <year>2015</year>
<volume>21</volume>
<fpage>544</fpage>
<lpage>552</lpage>
<pub-id pub-id-type="pmid">26101954</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>He</surname>
<given-names>XH</given-names>
</name>
<name>
<surname>Xin</surname>
<given-names>WJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Inhibition of NF-kappaB prevents mechanical allodynia induced by spinal ventral root transection and suppresses the re-expression of Nav1.3 in DRG neurons in vivo and in vitro</article-title>
<source/>Brain Res
          <year>2010</year>
<volume>1363</volume>
<fpage>151</fpage>
<lpage>158</lpage>
<pub-id pub-id-type="pmid">20858468</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bissay</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Van Malderen</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Keymolen</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SCN4A variants and Brugada syndrome: phenotypic and genotypic overlap between cardiac and skeletal muscle sodium channelopathies</article-title>
<source/>Eur J Hum Genet
          <year>2016</year>
<volume>24</volume>
<issue>3</issue>
<fpage>400</fpage>
<lpage>407</lpage>
<pub-id pub-id-type="pmid">26036855</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cannon</surname>
<given-names>SC</given-names>
</name>
</person-group>
<article-title>Channelopathies of skeletal muscle excitability</article-title>
<source/>Compr Physiol
          <year>2015</year>
<volume>5</volume>
<issue>2</issue>
<fpage>761</fpage>
<lpage>790</lpage>
<pub-id pub-id-type="pmid">25880512</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Millican-Slater</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nav1.5 regulates breast tumor growth and metastatic dissemination in vivo</article-title>
<source/>Oncotarget
          <year>2015</year>
<volume>6</volume>
<issue>32</issue>
<fpage>32914</fpage>
<lpage>32929</lpage>
<pub-id pub-id-type="pmid">26452220</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohammed</surname>
<given-names>FH</given-names>
</name>
<name>
<surname>Khajah</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Blockade of voltage-gated sodium channels inhibits invasion of endocrine-resistant breast cancer cells</article-title>
<source/>Int J Oncol
          <year>2016</year>
<volume>48</volume>
<issue>1</issue>
<fpage>73</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="pmid">26718772</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Musa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kline</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Sturm</surname>
<given-names>AC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SCN5A variant that blocks fibroblast growth factor homologous factor regulation causes human arrhythmia</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2015</year>
<volume>112</volume>
<issue>40</issue>
<fpage>12528</fpage>
<lpage>12533</lpage>
<pub-id pub-id-type="pmid">26392562</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>BY</given-names>
</name>
<name>
<surname>Yong</surname>
<given-names>RY</given-names>
</name>
<name>
<surname>Barajas-Martinez</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A Brugada syndrome proband with compound heterozygote SCN5A mutations identified from a Chinese family in Singapore</article-title>
<source/>Europace
          <year>2016</year>
<volume>18</volume>
<issue>6</issue>
<fpage>897</fpage>
<lpage>904</lpage>
<pub-id pub-id-type="pmid">25829473</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andrikopoulos</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Angiogenic functions of voltage-gated Na<sup>+</sup> channels in human endothelial cells: modulation of vascular endothelial growth factor (VEGF) signaling</article-title>
<source/>J Biol Chem
          <year>2011</year>
<volume>286</volume>
<issue>19</issue>
<fpage>16846</fpage>
<lpage>16860</lpage>
<pub-id pub-id-type="pmid">21385874</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Brien</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Meisler</surname>
<given-names>MH</given-names>
</name>
</person-group>
<article-title>Sodium channel SCN8A (Nav1.6): properties and de novo mutations in epileptic encephalopathy and intellectual disability</article-title>
<source/>Front Genet
          <year>2013</year>
<volume>4</volume>
<fpage>213</fpage>
<pub-id pub-id-type="pmid">24194747</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernandez-Plata</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ortiz</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Marquina-Castillo</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Overexpression of NaV 1.6 channels is associated with the invasion capacity of human cervical cancer</article-title>
<source/>Int J Cancer
          <year>2012</year>
<volume>130</volume>
<issue>9</issue>
<fpage>2013</fpage>
<lpage>2023</lpage>
<pub-id pub-id-type="pmid">21630263</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fertleman</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Ferrie</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Aicardi</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Paroxysmal extreme pain disorder (previously familial rectal pain syndrome)</article-title>
<source/>Neurology
          <year>2007</year>
<volume>69</volume>
<issue>6</issue>
<fpage>586</fpage>
<lpage>595</lpage>
<pub-id pub-id-type="pmid">17679678</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<mixed-citation publication-type="other">Suy S, Hansen TP, Auto HD et al. (2012) Expression of voltage-gated sodium channel Na(v)1.8 in human prostate cancer is associated with high histological grade. J Clin Exp Oncol. doi:10.4172/2324-9110.1000102</mixed-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Waxman</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>Sodium channel Nav1.8: emerging links to human disease</article-title>
<source/>Neurology
          <year>2016</year>
<volume>86</volume>
<issue>5</issue>
<fpage>473</fpage>
<lpage>483</lpage>
<pub-id pub-id-type="pmid">26747884</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roostaei</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sadaghiani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>MT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Channelopathy-related SCN10A gene variants predict cerebellar dysfunction in multiple sclerosis</article-title>
<source/>Neurology
          <year>2016</year>
<volume>86</volume>
<issue>5</issue>
<fpage>410</fpage>
<lpage>417</lpage>
<pub-id pub-id-type="pmid">26740675</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woods</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Babiker</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Horrocks</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The phenotype of congenital insensitivity to pain due to the NaV1.9 variant p. L811P</article-title>
<source/>Eur J Hum Genet
          <year>2015</year>
<volume>23</volume>
<issue>10</issue>
<fpage>1434</fpage>
<pub-id pub-id-type="pmid">26376683</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leipold</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hanson-Kahn</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Frick</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cold-aggravated pain in humans caused by a hyperactive NaV1.9 channel mutant</article-title>
<source/>Nat Commun
          <year>2015</year>
<volume>6</volume>
<fpage>10049</fpage>
<pub-id pub-id-type="pmid">26645915</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sodium channel Nax is a regulator in epithelial sodium homeostasis</article-title>
<source/>Sci Transl Med
          <year>2015</year>
<volume>7</volume>
<issue>312</issue>
<fpage>312ra177</fpage>
<pub-id pub-id-type="pmid">26537257</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hiyama</surname>
<given-names>TY</given-names>
</name>
</person-group>
<article-title>Sodium sensing in the brain</article-title>
<source/>Pflug Arch
          <year>2015</year>
<volume>467</volume>
<issue>3</issue>
<fpage>465</fpage>
<lpage>474</lpage>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheffer</surname>
<given-names>IE</given-names>
</name>
<name>
<surname>Harkin</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Grinton</surname>
<given-names>BE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations</article-title>
<source/>Brain
          <year>2007</year>
<volume>130</volume>
<issue>Pt 1</issue>
<fpage>100</fpage>
<lpage>109</lpage>
<pub-id pub-id-type="pmid">17020904</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Darbar</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kaiser</surname>
<given-names>DW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in sodium channel beta1- and beta2-subunits associated with atrial fibrillation</article-title>
<source/>Circ Arrhythm Electrophysiol
          <year>2009</year>
<volume>2</volume>
<fpage>268</fpage>
<lpage>275</lpage>
<pub-id pub-id-type="pmid">19808477</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roger</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rollin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Barascu</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Voltage-gated sodium channels potentiate the invasive capacities of human non-small-cell lung cancer cell lines</article-title>
<source/>Int J Biochem Cell Biol
          <year>2007</year>
<volume>39</volume>
<fpage>774</fpage>
<lpage>786</lpage>
<pub-id pub-id-type="pmid">17307016</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Malley</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Shreiner</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>GH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Loss of Na<sup>+</sup> channel beta2 subunits is neuroprotective in a mouse model of multiple sclerosis</article-title>
<source/>Mol Cell Neurosci
          <year>2009</year>
<volume>40</volume>
<issue>2</issue>
<fpage>143</fpage>
<lpage>155</lpage>
<pub-id pub-id-type="pmid">19013247</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oyama</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Miyazaki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sakamoto</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sodium channel beta4 subunit: down-regulation and possible involvement in neuritic degeneration in Huntington’s disease transgenic mice</article-title>
<source/>J Neurochem
          <year>2006</year>
<volume>98</volume>
<issue>2</issue>
<fpage>518</fpage>
<lpage>529</lpage>
<pub-id pub-id-type="pmid">16805843</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Isom</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>De Jongh</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Patton</surname>
<given-names>DE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Primary structure and functional expression of the beta 1 subunit of the rat brain sodium channel</article-title>
<source/>Science
          <year>1992</year>
<volume>256</volume>
<issue>5058</issue>
<fpage>839</fpage>
<lpage>842</lpage>
<pub-id pub-id-type="pmid">1375395</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Isom</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Ragsdale</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>De Jongh</surname>
<given-names>KS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structure and function of the beta 2 subunit of brain sodium channels, a transmembrane glycoprotein with a CAM motif</article-title>
<source/>Cell
          <year>1995</year>
<volume>83</volume>
<issue>3</issue>
<fpage>433</fpage>
<lpage>442</lpage>
<pub-id pub-id-type="pmid">8521473</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>beta 3: an additional auxiliary subunit of the voltage-sensitive sodium channel that modulates channel gating with distinct kinetics</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2003</year>
<volume>97</volume>
<issue>5</issue>
<fpage>2308</fpage>
<lpage>2313</lpage>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>FH</given-names>
</name>
<name>
<surname>Westenbroek</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Silos-Santiago</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sodium channel beta4, a new disulfide-linked auxiliary subunit with similarity to beta2</article-title>
<source/>J Neurosci
          <year>2003</year>
<volume>23</volume>
<issue>20</issue>
<fpage>7577</fpage>
<lpage>7585</lpage>
<pub-id pub-id-type="pmid">12930796</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Black</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Westenbroek</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ransom</surname>
<given-names>BR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Type II sodium channels in spinal cord astrocytes in situ: immunocytochemical observations</article-title>
<source/>Glia
          <year>1994</year>
<volume>12</volume>
<fpage>219</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="pmid">7851989</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reese</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Caldwell</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Immunocytochemical localization of NaCh6 in cultured spinal cord astrocytes</article-title>
<source/>Glia
          <year>1999</year>
<volume>26</volume>
<fpage>92</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="pmid">10088676</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Black</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Dib-Hajj</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Glial cells have heart: rH1 Na<sup>+</sup> channel mRNA and protein in spinal cord astrocytes</article-title>
<source/>Glia
          <year>1998</year>
<volume>23</volume>
<fpage>200</fpage>
<lpage>208</lpage>
<pub-id pub-id-type="pmid">9633805</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barres</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Chun</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Corey</surname>
<given-names>DP</given-names>
</name>
</person-group>
<article-title>Glial and neuronal forms of the voltage-dependent sodium channel: characteristics and cell-type distribution</article-title>
<source/>Neuron
          <year>1989</year>
<volume>2</volume>
<fpage>1375</fpage>
<lpage>1388</lpage>
<pub-id pub-id-type="pmid">2560639</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herzog</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Waxman</surname>
<given-names>SG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Calmodulin binds to the C terminus of sodium channels Nav1.4 and Nav1.6 and differentially modulates their functional properties</article-title>
<source/>J Neurosci
          <year>2003</year>
<volume>23</volume>
<fpage>8261</fpage>
<lpage>8270</lpage>
<pub-id pub-id-type="pmid">12967988</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kapoor</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Sodium channel blockers and neuroprotection in multiple sclerosis using lamotrigine</article-title>
<source/>J Neurolog Sci
          <year>2008</year>
<volume>274</volume>
<issue>1–2</issue>
<fpage>54</fpage>
<lpage>56</lpage>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nikolaeva</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Stys</surname>
<given-names>PK</given-names>
</name>
</person-group>
<article-title>Na<sup>+</sup>-dependent sources of intra-axonal Ca<sup>2+</sup> release in rat optic nerve during in vitro chemical ischemia</article-title>
<source/>J Neurosci
          <year>2005</year>
<volume>25</volume>
<fpage>9960</fpage>
<lpage>9967</lpage>
<pub-id pub-id-type="pmid">16251444</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waxman</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>Mechanisms of disease: sodium channels and neuroprotection in multiple sclerosis current status</article-title>
<source/>Nat Clin Pract Neurol
          <year>2008</year>
<volume>4</volume>
<issue>3</issue>
<fpage>159</fpage>
<lpage>169</lpage>
<pub-id pub-id-type="pmid">18227822</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pappalardo</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Samad</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>JA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Voltage-gated sodium channel Nav 1.5 contributes to astrogliosis in an in vitro model of glial injury via reverse Na<sup>+</sup>/Ca<sup>2+</sup> exchange</article-title>
<source/>Glia
          <year>2014</year>
<volume>62</volume>
<issue>7</issue>
<fpage>1162</fpage>
<lpage>1175</lpage>
<pub-id pub-id-type="pmid">24740847</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bechtold</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Kapoor</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>KJ</given-names>
</name>
</person-group>
<article-title>Axonal protection using flecainide in experimental autoimmune encephalomyelitis</article-title>
<source/>Ann Neurol
          <year>2004</year>
<volume>55</volume>
<issue>5</issue>
<fpage>607</fpage>
<lpage>616</lpage>
<pub-id pub-id-type="pmid">15122700</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morsali</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bechtold</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis</article-title>
<source/>Brain
          <year>2013</year>
<volume>136</volume>
<issue>Pt 4</issue>
<fpage>1067</fpage>
<lpage>1082</lpage>
<pub-id pub-id-type="pmid">23518709</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lo</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Waxman</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis</article-title>
<source/>Neuroreport
          <year>2002</year>
<volume>13</volume>
<fpage>1909</fpage>
<lpage>1912</lpage>
<pub-id pub-id-type="pmid">12395089</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bechtold</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Dawson</surname>
<given-names>AC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Axonal protection achieved in a model of multiple sclerosis using lamotrigine</article-title>
<source/>J Neurol
          <year>2006</year>
<volume>253</volume>
<fpage>1542</fpage>
<lpage>1551</lpage>
<pub-id pub-id-type="pmid">17219031</pub-id>
</element-citation>
</ref>
<ref id="CR118">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Craner</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Damarjian</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sodium channels contribute to microglia/macrophage activation and function in EAE and MS</article-title>
<source/>Glia
          <year>2005</year>
<volume>49</volume>
<issue>2</issue>
<fpage>220</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="pmid">15390090</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Counihan</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Duignan</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Gormley</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Does long-term partial sodium channel blockade alter disease progression in MS? Evidence from a retrospective study</article-title>
<source/>Ir J Med Sci
          <year>2014</year>
<volume>183</volume>
<issue>1</issue>
<fpage>117</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="pmid">24287594</pub-id>
</element-citation>
</ref>
<ref id="CR120">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gnanapavan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Morant</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Biomarker report from the phase II lamotrigine trial in secondary progressive MS- neurofilament as a surrogate of disease progression</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<issue>8</issue>
<fpage>e70019</fpage>
<pub-id pub-id-type="pmid">23936370</pub-id>
</element-citation>
</ref>
<ref id="CR121">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kapoor</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Furby</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hayton</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial</article-title>
<source/>Lancet Neurol
          <year>2010</year>
<volume>9</volume>
<issue>7</issue>
<fpage>681</fpage>
<lpage>688</lpage>
<pub-id pub-id-type="pmid">20621711</pub-id>
</element-citation>
</ref>
<ref id="CR122">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleinewietfeld</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Manzel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Titze</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells</article-title>
<source/>Nature
          <year>2013</year>
<volume>496</volume>
<issue>7446</issue>
<fpage>518</fpage>
<lpage>522</lpage>
<pub-id pub-id-type="pmid">23467095</pub-id>
</element-citation>
</ref>
<ref id="CR123">
<label>123.</label>
<mixed-citation publication-type="other">McGuire S (2010) Institute of Medicine. 2010. Strategies to reduce sodium intake in the United States. The National Academies Press, Washington. Adv Nutr 1:49–50</mixed-citation>
</ref>
<ref id="CR124">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Appel</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Frohlich</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>JE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association</article-title>
<source/>Circulation
          <year>2011</year>
<volume>123</volume>
<fpage>1138</fpage>
<lpage>1143</lpage>
<pub-id pub-id-type="pmid">21233236</pub-id>
</element-citation>
</ref>
<ref id="CR125">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>IJ</given-names>
</name>
<name>
<surname>Tzoulaki</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Candeias</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Salt intakes around the world: implications for public health</article-title>
<source/>Int J Epidemiol
          <year>2009</year>
<volume>38</volume>
<fpage>791</fpage>
<lpage>813</lpage>
<pub-id pub-id-type="pmid">19351697</pub-id>
</element-citation>
</ref>
<ref id="CR126">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Junger</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>FC</given-names>
</name>
<name>
<surname>Loomis</surname>
<given-names>WH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hypertonic saline enhances cellular immune function</article-title>
<source/>Circ Shock
          <year>1994</year>
<volume>42</volume>
<fpage>190</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="pmid">8055665</pub-id>
</element-citation>
</ref>
<ref id="CR127">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Machnik</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Neuhofer</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Jantsch</surname>
</name>
<etal></etal>
</person-group>
<article-title>Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism</article-title>
<source/>Nat Med
          <year>2009</year>
<volume>15</volume>
<issue>5</issue>
<fpage>545</fpage>
<lpage>552</lpage>
<pub-id pub-id-type="pmid">19412173</pub-id>
</element-citation>
</ref>
<ref id="CR128">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korn</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bettelli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Oukka</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>IL-17 and Th17 Cells</article-title>
<source/>Annu Rev Immunol
          <year>2009</year>
<volume>27</volume>
<fpage>485</fpage>
<lpage>517</lpage>
<pub-id pub-id-type="pmid">19132915</pub-id>
</element-citation>
</ref>
<ref id="CR129">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghoreschi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Laurence</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>XP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling</article-title>
<source/>Nature
          <year>2010</year>
<volume>467</volume>
<fpage>967</fpage>
<lpage>971</lpage>
<pub-id pub-id-type="pmid">20962846</pub-id>
</element-citation>
</ref>
<ref id="CR130">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yosef</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Thalhamer</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1</article-title>
<source/>Nature
          <year>2013</year>
<volume>496</volume>
<issue>7446</issue>
<fpage>513</fpage>
<lpage>517</lpage>
<pub-id pub-id-type="pmid">23467085</pub-id>
</element-citation>
</ref>
<ref id="CR131">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Codarri</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gyülvészi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tosevski</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation</article-title>
<source/>Nat Immunol
          <year>2011</year>
<volume>12</volume>
<fpage>560</fpage>
<lpage>567</lpage>
<pub-id pub-id-type="pmid">21516112</pub-id>
</element-citation>
</ref>
<ref id="CR132">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Behi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ciric</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF</article-title>
<source/>Nat Immunol
          <year>2011</year>
<volume>12</volume>
<fpage>568</fpage>
<lpage>575</lpage>
<pub-id pub-id-type="pmid">21516111</pub-id>
</element-citation>
</ref>
<ref id="CR133">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reboldi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Coisne</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Baumjohann</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE</article-title>
<source/>Nat Immunol
          <year>2009</year>
<volume>10</volume>
<fpage>514</fpage>
<lpage>523</lpage>
<pub-id pub-id-type="pmid">19305396</pub-id>
</element-citation>
</ref>
<ref id="CR134">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Go</surname>
<given-names>WY</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Roti</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>NFAT5/TonEBP mutant mice define osmotic stress as acritical feature of the lymphoid microenvironment</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2004</year>
<volume>101</volume>
<fpage>10673</fpage>
<lpage>10678</lpage>
<pub-id pub-id-type="pmid">15247420</pub-id>
</element-citation>
</ref>
<ref id="CR135">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farez</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Fiol</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Gaitán</surname>
<given-names>MI</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sodium intake is associated with increased disease activity in multiple sclerosis</article-title>
<source/>J Neurol Neurosurg Psychiatry
          <year>2015</year>
<volume>86</volume>
<issue>1</issue>
<fpage>26</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="pmid">25168393</pub-id>
</element-citation>
</ref>
<ref id="CR136">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fulgoni</surname>
<given-names>VL</given-names>
<suffix>3rd</suffix>
</name>
</person-group>
<article-title>Limitations of data on fluid intake</article-title>
<source/>J Am Coll Nutr
          <year>2007</year>
<volume>26</volume>
<issue>5 Suppl</issue>
<fpage>588S</fpage>
<lpage>591S</lpage>
<pub-id pub-id-type="pmid">17921470</pub-id>
</element-citation>
</ref>
<ref id="CR137">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>SI</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>DB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets</article-title>
<source/>Nature
          <year>2008</year>
<volume>451</volume>
<issue>7182</issue>
<fpage>1076</fpage>
<lpage>1081</lpage>
<pub-id pub-id-type="pmid">18278032</pub-id>
</element-citation>
</ref>
<ref id="CR138">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodfriend</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Elliott</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Catt</surname>
<given-names>KJ</given-names>
</name>
</person-group>
<article-title>Angiotensin receptors and their antagonists</article-title>
<source/>N Engl J Med
          <year>1996</year>
<volume>334</volume>
<fpage>1649</fpage>
<lpage>1654</lpage>
<pub-id pub-id-type="pmid">8628362</pub-id>
</element-citation>
</ref>
<ref id="CR139">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stegbauer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Seubert</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2009</year>
<volume>106</volume>
<fpage>14942</fpage>
<lpage>14947</lpage>
<pub-id pub-id-type="pmid">19706425</pub-id>
</element-citation>
</ref>
<ref id="CR140">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maillard</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Seshadri</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Beiser</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study</article-title>
<source/>Lancet Neurol
          <year>2012</year>
<volume>11</volume>
<fpage>1039</fpage>
<lpage>1047</lpage>
<pub-id pub-id-type="pmid">23122892</pub-id>
</element-citation>
</ref>
<ref id="CR141">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Platten</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Youssef</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hur</surname>
<given-names>EM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2009</year>
<volume>106</volume>
<issue>35</issue>
<fpage>14948</fpage>
<lpage>14953</lpage>
<pub-id pub-id-type="pmid">19706421</pub-id>
</element-citation>
</ref>
<ref id="CR142">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hucke</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Eschborn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liebmann</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sodium chloride promotes pro-inflammatory macrophage polarization thereby aggravating CNS autoimmunity</article-title>
<source/>J Autoimmun
          <year>2016</year>
<volume>67</volume>
<fpage>90</fpage>
<lpage>101</lpage>
<pub-id pub-id-type="pmid">26584738</pub-id>
</element-citation>
</ref>
<ref id="CR143">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yi</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Titze</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rykova</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of dietary salt levels on monocytic cells and immune responses in healthy human subjects: a longitudinal study</article-title>
<source/>Transl Res
          <year>2015</year>
<volume>166</volume>
<issue>1</issue>
<fpage>103</fpage>
<lpage>110</lpage>
<pub-id pub-id-type="pmid">25497276</pub-id>
</element-citation>
</ref>
<ref id="CR144">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jörg</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kissel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Manzel</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High salt drives Th17 responses in experimental autoimmune encephalomyelitis without impacting myeloid dendritic cells</article-title>
<source/>Exp Neurol
          <year>2016</year>
<volume>279</volume>
<fpage>212</fpage>
<lpage>222</lpage>
<pub-id pub-id-type="pmid">26976739</pub-id>
</element-citation>
</ref>
<ref id="CR145">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krementsov</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Case</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Hickey</surname>
<given-names>WF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Exacerbation of autoimmune neuroinflammation by dietary sodium is genetically controlled and sex specific</article-title>
<source/>FASEB J
          <year>2015</year>
<volume>29</volume>
<issue>8</issue>
<fpage>3446</fpage>
<lpage>3457</lpage>
<pub-id pub-id-type="pmid">25917331</pub-id>
</element-citation>
</ref>
<ref id="CR146">
<label>146.</label>
<mixed-citation publication-type="other">Zhou X, Zhang L, Ji WJ et al (2013) Variation in dietary salt intake induces coordinated dynamics of monocyte subsets and monocyte-platelet aggregates in humans: implications in end organ inflammation. In: Zirlik A (ed) PLoS One 8(4):e60332</mixed-citation>
</ref>
<ref id="CR147">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernandez</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Kitz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells</article-title>
<source/>J Clin Investig
          <year>2015</year>
<volume>125</volume>
<issue>11</issue>
<fpage>4212</fpage>
<lpage>4222</lpage>
<pub-id pub-id-type="pmid">26524592</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>